Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

TRVITRVI

Showing 8 of 16 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in TREVI THERAPEUTICS INC

Yes. Viking Global Investors holds 1,544,644 shares of TRVI (Trevi Therapeutics), worth $28.8M, as of its Q2 2026 13F filing. It reduced the position by 1,654,000 shares (-51.7%) from Q1 2026. Viking Global Investors has held TRVI since Q3 2022, across 16 quarterly 13F filings. TRVI is 0.1% of Viking Global Investors' reported 13F portfolio.

Current Value

$28.8M

Current Shares

1.5M

Total Value Change

+$14.1M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-51.7%
$28.8M0.1%$18.65
0
2026-Q1
Unchanged
3.2M
0.0%
$38.2M0.1%$12.26
0
2025-Q4
Decreased
3.2M
-37.6%
$40M0.1%$12.56
0
2025-Q3
Increased
5.1M
+232.4%
$46.9M0.1%$8.95
56
2025-Q2
Decreased
1.5M
-52.2%
$8.4M0.0%$5.62
0
2025-Q1
Decreased
3.2M
-26.6%
$20.3M0.1%$6.50
0
2024-Q4
Unchanged
4.4M
0.0%
$18.1M0.1%$4.10
0
2024-Q3
Unchanged
4.4M
0.0%
$14.7M0.1%$3.33
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used